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Health-related quality-of-life and well-being are two import-
ant outcome measures for inpatients attending alcohol treat-
ment programs. Rapid improvement in well-being and health
related quality-of-life may be a possible way to motivate
ambivalent patients to undergo detoxification.
The present letter is an ancillary report of a randomized
controlled trial on pharmacological management of alcohol
withdrawal. It focuses on changes in patients’ perception of
well-being and health-related quality-of-life over the first
3 days of inpatient detoxification.
During a 12-month period, consecutive patients admitted to
an alcohol treatment inpatient unit were considered for inclu-
sion. The selection process was described in the principal
report (Daeppen et al., 2002). Subjects’ well-being and per-
ceived health-related quality of life were assessed at intake
using four questions from the well-being schedule
(McDowell and Newell, 1996) and three dimensions from
the MOS-SF-36 (physical functioning, vitality, and mental
health) (Ware and Sherbourne, 1992). Perceived well-being
and health-related quality life were measured again at with-
drawal day 4 using similar measures adapted to reflect the
three first detoxification days. Wilcoxon tests were used to
compare health-related measures between withdrawal days 1
and 4. Among the 126 included individuals, 4 left the pro-
gramme within the first 3 days, 3 had exclusion criteria appar-
ent only after inclusion, 1 had somnolence and 1 had several
falls, resulting in a 117 (92.9 %) patient sample. The
mean ± SD age was 46.6 ± 9.52 years; 76.9% were men
(n = 90); 94.9% were white (n = 111).
Compared to withdrawal day 1, all mean scores were statist-
ically improved at withdrawal day 4 toward a self-perception
of a better functioning and health: health concerns score
(3.72 vs 5.97, Z = –5.68, P < 0.001), anxiety score (3.84 vs
6.9, Z = –7.46, P < 0.001), energy score (5.43 vs 3.93, Z =
–5.20, P < 0.001), feeling good vs. depressed score (6.12 vs
3.9, Z = –7.06, P < 0.001), physical functioning (MOS-SF-
36) (87.91 vs 84.30, Z = –4.08, P < 0.001), vitality (MOS-
SF-36) (57.61 vs 42.87, Z = –6.85, P < 0.001), and mental
health (MOS-SF-36) (66.99 vs 46.26, Z = –7.91, P < 0.001).
This letter suggests rapid improvement in all examined
dimensions of perceived well-being and health-related quality
of life over the first 3 days of alcohol withdrawal among
alcohol-dependent individuals. The data reported are consist-
ent with observations on perceived health-related quality-of-
life associated with abstinence published in the literature
(Foster et al., 1999). These findings may be used as a motiva-
tional tool to encourage alcohol-dependent patients to undergo
detoxification and as positive feedback for patients’ during
early alcohol withdrawal.
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